Irbesartan chemical structure
Find information on thousands of medical conditions and prescription drugs.

Irbesartan

Irbesartan is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. Irbesartan was discovered by Sanofi Research (now part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the trade names Aprovel®, Karvea®, and Avapro®. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
Ibuprofen
Idarubicin
Idebenone
IFEX
Iloprost
Imatinib mesylate
Imdur
Imipenem
Imipramine
Imiquimod
Imitrex
Imodium
Indahexal
Indapamide
Inderal
Indocin
Indometacin
Infliximab
INH
Inosine
Intal
Interferon gamma
Intralipid
Invanz
Invirase
Iontocaine
Iotrolan
Ipratropium bromide
Iproniazid
Irbesartan
Iressa
Irinotecan
Isocarboxazid
Isoflurane
Isohexal
Isoleucine
Isomonit
Isoniazid
Isoprenaline
Isordil
Isosorbide
Isosorbide dinitrate
Isosorbide mononitrate
Isotretinoin
Itraconazole
Ivermectin
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Irbesartan is one of the class that patients may be prescribed if they cannot tolerate the ACE-inhibitor drugs, such as perindopril. The usual reason is because of dry cough, attributed to delayed breakdown of bradykinin by ACE. Irbesartan may help to delay the progression of diabetic nephropathy, a form of chronic renal failure due to diabetes.

Irbesartan is also available in a combination formulation with hydrochlorothiazide, marketed as CoAprovel®.

Read more at Wikipedia.org


[List your site here Free!]


Cyclosporine After Punctal Plugs
From Optometric Management, 11/1/05

A postmenopausal woman with a 5-year history of dry, scratchy burning eyes reported experiencing constant discomfort, despite hourly application of artificial tears Her past medical history was notable for mild hypertension and depression treated with irbesartan (Avapro) and citalopran (Celexa), respectively.

Physical examination revealed best-corrected visual acuity of 20/25 and mild superficial punctate keratitis (SPK) inferior to the central corneal apex in both eyes.

Dry eye syndrome (DES) was confirmed by Schirmer's test and the presence of bilateral punctate staining with rose bengal at the limbus at four- and eight o'clock.

The patient was treated initially with lower punctal plugs and hourly applications of artificial tears, but she returned 2 weeks later, complaining the burning sensation was much worse.

Examination revealed no change in the central SPK but increased rose bengal conjunctival staining. The punctal plugs were removed, and the patient began using cyclosporine ophthalmic emulsion 0.05% (Restasis) twice a day while continuing to apply artificial tears.

After using cyclosporine 0.05% for 1 month, the patient reported improved symptoms. Decreased SPK and rose bengal staining confirmed clinical progress.

The patient continued using cyclosporine 0.05% for the next 3 months, after which her SPK and burning discomfort resolved. The patient reported she now uses artificial tears just three times a day.

Copyright Boucher Communications, Inc. Nov 2005
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Irbesartan
Home Contact Resources Exchange Links ebay